Discovery Studio, BIOVIA’s most extensive 3D modeling and simulation solution for drug discovery, is now available both as Software as a service (SaaS) and an on-prem application.
Discovery Studio is a powerful software suite widely used for 3D molecular modeling, simulation, and visualization. It combines world-class in silico techniques and over 30 years of peer-reviewed research into a shared environment, providing molecular modelers with a complete toolset. With Discovery Studio, researchers can explore the nuances of protein chemistry and catalyze discovery of small and large molecule therapeutics from Target ID to Lead Optimization.
Discovery Studio Simulation, the cloud-based version, is available on the 3DEXPERIENCE platform, offering several benefits over the desktop version. First, it eliminates the need for hardware upgrades and installations, making it easier and more cost-effective for researchers to access the software. It also provides greater flexibility and scalability, allowing scientists to run multiple simulations simultaneously and scale up or down as needed. Finally, as a platform-based application, with Discovery Studio Simulation, users may access other applications on the 3DEXPERIENCE platform, supporting end-to-end small molecule drug discovery. These applications include:
- BIOVIA Generative Therapeutics Design – An AI-driven solution for accelerating small molecule therapeutics design
- BIOVIA Insight for Research – A solution for data analysis, providing data-driven insights while collaborating with internal teams and across networked external organizations
- BIOVIA Materials Registration – A cloud-based, out-of-the-box system that enables registration, searching and reporting on a variety of biological entities, including antibodies, cell lines, plasmids, proteins, nucleic acids and more
- BIOVIA Scientific Notebook – A cloud-native ELN that takes a data-centric approach instead of the document-centric one
For those who prefer an on-prem version, the latest major version has been released: Discovery Studio 2023 SP1, compatible with Pipeline Pilot 2023 SP1. Packed with novel features and enhancements, this latest version includes a new Gaussian accelerated Molecular Dynamics (GaMD) method for simultaneous unconstrained enhanced sampling and free energy calculations, a new machine learning method to humanize antibody sequences and more. We are also preparing for another release of Discovery Studio on-prem, to come before the end of the year.
So, it’s your choice: In the cloud or on your premise. Regardless of which solution you choose, BIOVIA Discovery Studio is committed to delivering superior 3D modeling and simulation (MODSIM) tools incorporating cutting-edge science and technology, enhancing your R&D teams’ daily productivity for years to come.